Home Health News Drug Cuts Nausea From GLP-1 Drugs; ‘Female Viagra’ Boom; Semaglutide and Alcohol Use By News Health 26 minutes Ago Share on FacebookShare on Twitter (MedPage Today) — Vanda Pharmaceuticals said its investigational neurokinin-1 receptor antagonist tradipitant reduced nausea and vomiting from semaglutide (Ozempic, Wegovy) in a randomized trial of people with obesity or overweight. A KFF poll… Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/118581 Author : Publish date : 2025-11-18 19:01:00 Copyright for syndicated content belongs to the linked Source. Categories: Health News Related Content YesRx: Michigan Program Turns Cancer Drug Waste Into Hope By News Health November 18, 2025 Medicine Needs a 'Millennialist' Sub-Specialty By News Health November 18, 2025 Private Prescribing Undercuts NHS Antibiotic Reductions By News Health November 18, 2025 Navigating Second-Line Endocrine Options in Breast Cancer By News Health November 18, 2025 When Ditching Dialysis Makes Sense for Older Adults By News Health November 18, 2025 South Carolina Lawmakers Look at the Most Restrictive Abortion Bill in the U.S. By News Health November 18, 2025